Asset sale Completed
Adial Pharmaceuticals acquisition of Azora Therapeutics
NASDAQ: AZR
Advisers
- Target
- Azora Therapeutics
- Acquirer
- Adial Pharmaceuticals
- Target based in
- United States
- Buyer based in
- United States
- Completed
- 11 Jun 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Pharma
In the league tables
Similar deals
- Hansoh Pharmaceutical Group Co. stake in Avere Therapeutics Jul 2026 · Biotech
- Amneal Pharmaceuticals acquisition of Kashiv BioSciences Apr 2026 · US$375m · Biotech
- Eli Lilly and Company acquisition of Ventyx Biosciences Jan 2026 · US$1.2bn · Biotech
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
